YATHARTH NSE filing

Yatharth Hospital Approves ₹3,150 Crore Preferential Issue to Rasmalai Ltd

The RealCase readHigh impact Positive

Yatharth Hospital approved a preferential issue of equity shares and warrants worth ₹3,150 crore to Rasmalai Limited. This includes 1.3 crore shares and 1.89 crore warrants at ₹985.17 each. The deal represents a 24.87% stake. An EGM is scheduled for October 15, 2026, to approve the proposals.

Why it matters

The preferential issue is substantial in value (₹3,150 crore) and represents a significant stake (24.87%) in the company, which will impact the capital structure and potentially the future strategic direction.

The market read

The company is raising a significant amount of capital through a preferential issue, which is generally seen as positive for growth and expansion. The approval of amendments to MOA/AOA and the engagement with a foreign investor indicate strategic moves.

Yatharth Hospital & Trauma Care Services Limited's Board of Directors, in a meeting held on September 17, 2026, has approved a significant preferential issue of equity shares and warrants to Rasmalai Limited, a Cyprus-based company, for a total consideration of up to ₹3,150.00 crore.

This issuance includes up to 1,30,26,516 equity shares at an issue price of ₹985.17 per share, amounting to ₹1,283.33 crore, and up to 1,89,47,664 warrants at the same price, with 25% payable upfront. The total subscription consideration aggregates to ₹3,150.00 crore, representing a 24.87% stake in the company on a fully diluted basis post-transaction. The company also approved an increase in its authorized share capital from ₹115 crore to ₹150 crore.

The Board further approved the adoption of amended and restated Articles of Association, incorporating special rights for the investor and promoters. An upside share arrangement was also approved, allowing a promoter to receive a portion of the investor's profits upon divestment. The company will convene an Extra-Ordinary General Meeting (EGM) on October 15, 2026, to seek shareholder approval for these proposals, including the preferential issue and amendments to the Memorandum and Articles of Association.

Filing to action

What to do with a filing like this

Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.

View original filing